严重低血糖对退伍军人事务部糖尿病试验心血管结局与死亡的影响
该研究为VADT事后分析,纳入1791例血糖控制不佳的2型糖尿病退伍军人,随机接受强化(HbA1c<7.0%)或标准(HbA1c<8.5%)降糖治疗。结果显示强化组严重低血糖发生率显著高于标准组(10.3 vs 3.7/100患者年,P<0.001),且近3个月内严重低血糖与严重心血管事件、心血管死亡及全因死亡风险增加相关。
要点
- 强化降糖组严重低血糖发生率显著高于标准组(10.3 vs 3.7/100患者年)。
- 基线胰岛素使用、蛋白尿和自主神经病变是严重低血糖独立危险因素。
- 近3个月严重低血糖与心血管事件、心血管死亡及全因死亡风险增加相关。
核心结论
- 近3个月内发生严重低血糖与主要心血管事件、心血管死亡及全因死亡风险增加相关,且不受降糖治疗分组影响。
- 标准治疗组在发生严重低血糖后全因死亡风险进一步增加。
研究设计与样本
- VADT事后分析,纳入1791例军事退伍军人(年龄60.5±9.0岁),2型糖尿病控制不佳(HbA1c 9.4±2.0%),病程11.5±7.5年。
- 参与者随机接受强化治疗(HbA1c<7.0%)或标准治疗(HbA1c<8.5%)。
主要发现
- 强化治疗组严重低血糖发生率为10.3/100患者年,标准治疗组为3.7/100患者年(P<0.001)。
- 多变量分析中,基线胰岛素使用(P=0.02)、蛋白尿(P=0.009)和自主神经病变(P=0.01)是严重低血糖的独立危险因素,较高BMI具有保护作用(P=0.017)。
- 近3个月内严重低血糖与严重心血管事件(P=0.032)、心血管死亡(P=0.012)和全因死亡(P=0.024)风险增加相关。
- 标准治疗组相比强化治疗组,严重低血糖后全因死亡风险增加更显著(P=0.019)。
- 严重低血糖与心血管事件的关联随总体心血管风险增加而显著增强(P=0.012)。
临床怎么用
- 对使用胰岛素、合并蛋白尿或自主神经病变的2型糖尿病患者,应警惕严重低血糖风险并加强监测。
- 发生严重低血糖后应评估心血管风险,尤其标准降糖治疗者需关注全因死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the risk factors for severe hypoglycemia and the association between severe hypoglycemia and serious cardiovascular adverse events and cardiovascular and all-cause mortality in the Veterans Affairs Diabetes Trial (VADT). RESEARCH DESIGN AND METHODS: This post hoc analysis of data from the VADT included 1,791 military veterans (age 60.5 ± 9.0 years) with suboptimally controlled type 2 diabetes (HbA1c 9.4 ± 2.0%) of 11.5 ± 7.5 years disease duration with or without known cardiovascular disease and additional cardiovascular risk factors. Participants were randomized to intensive (HbA1c <7.0%) versus standard (HbA1c <8.5%) glucose control. RESULTS: The rate of severe hypoglycemia in the intensive treatment group was 10.3 per 100 patient-years compared with 3.7 per 100 patient-years in the standard treatment group (P < 0.001). In multivariable analysis, insulin use at baseline (P = 0.02), proteinuria (P = 0.009), and autonomic neuropathy (P = 0.01) were independent risk factors for severe hypoglycemia, and higher BMI was protective (P = 0.017). Severe hypoglycemia within the past 3 months was associated with an increased risk of serious cardiovascular events (P = 0.032), cardiovascular mortality (P = 0.012), and total mortality (P = 0.024). However, there was a relatively greater increased risk for total mortality in the standard group compared with the intensive group (P = 0.019). The association between severe hypoglycemia and cardiovascular events increased significantly as overall cardiovascular risk increased (P = 0.012). CONCLUSIONS: Severe hypoglycemic episodes within the previous 3 months were associated with increased risk for major cardiovascular events and cardiovascular and all-cause mortality regardless of glycemic treatment group assignment. Standard therapy further increased the risk for all-cause mortality after severe hypoglycemia.
引用
- Davis SN, Duckworth W, Emanuele N, et al. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Diabetes Care. 2018. PMID: 30455335. doi:10.2337/dc18-1144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。